Invention Application
- Patent Title: COMBINATION OF 25-HYDROXYVITAMIN D AND ANTIOXIDANTS/ANTI-INFLAMMATORIES FOR HUMAN NUTRACEUTICALS
-
Application No.: US15541793Application Date: 2016-01-15
-
Publication No.: US20190015429A1Publication Date: 2019-01-17
- Inventor: Shuen Ei CHEN , Thau Kiong CHUNG , Daniel RAEDERSTORFF , Wolfgang SCHALCH
- Applicant: DSM IP ASSETS B.V.
- Priority: EP15166937.1 20150508; EP15172721.1 20150618
- International Application: PCT/EP2016/050762 WO 20160115
- Main IPC: A61K31/593
- IPC: A61K31/593 ; A23L33/155 ; A23K20/174 ; A23K50/75 ; A23K20/179 ; A61K31/375 ; A61K31/355 ; A61K31/015 ; A61K31/047 ; A61K31/01 ; A61K31/122 ; A61P15/08 ; A61P3/04 ; A61P9/00 ; A61P3/06 ; A61P3/10 ; A61K31/525 ; A61K31/675 ; A61K31/455 ; A61K31/197 ; A61K31/519 ; A61K31/4188 ; A61K33/30 ; A61K33/34 ; A61K33/32 ; A61K33/04
Abstract:
This invention relates to the use of the combination of 25-hydroxyvitamin D3 (“25-OH D3”) and antioxidants/anti-inflammatories (ascorbic acid, vitamin E and at least one carotenoid) to make a pharmaceutical, nutraceutical or food supplement which can ameliorate various problems observed in humans connected with polycystic ovarian 5 syndrome and cardiovascular diseases. Pharmaceuticals, nutraceuticals and food supplements containing the 25-OH D3 and antioxidants/anti-inflammatories and premixes are also provided.
Public/Granted literature
- US10668088B2 Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for human nutraceuticals Public/Granted day:2020-06-02
Information query
